Insights

  • Home
  • Insights
  • Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

Share

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

Hong Kong Exchange Publishes Draft Rules for Biotech Listings, Requests Comments

March 09, 2018 Commentary

The Stock Exchange of Hong Kong Limited (the "Exchange") published the Consultation Paper on a Listing Regime for Companies from Emerging and Innovative Sectors on February 23, 2018 (the "Consultation Paper"), and proposed to introduce a new chapter ("Chapter 18A") to the Main Board Listing Rules (the "Listing Rules") to implement the proposal of allowing the listing of pre-revenue/pre-profit biotech companies on the Main Board of the Exchange (the "Main Board").

The Consultation Paper clarifies uncertainties in the previous proposal (particularly on determining whether a product has been developed beyond the concept stage) and enables biotech companies seeking listing in Hong Kong to effectively assess if they could meet the relevant requirements.

This Jones Day White Paper reviews key points in the Consultation Paper.

Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.
Contributors
You May Also Be Interested In

Firm Hosted

2025 Public Company Speaker Series

May 12, 2025 Commentary

Constitutional Reform in Mexican Electricity Sector

April 14, 2025 Reprint

United States Venture Capital (Legal 500 Country Comparative Guide)

April 09, 2025 Commentary

SEC Division of Corporation Finance: Certain U.S. Dollar-Backed Stablecoins Are Not Securities

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.